ADMA Biologics, Inc. (ADMA)
8.475
+0.10
(+1.13%)
USD |
NASDAQ |
May 19, 14:31
ADMA Biologics Research and Development Expense (Quarterly) : 2.597M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 2.661M |
| Inovio Pharmaceuticals, Inc. | 13.75M |
| ACADIA Pharmaceuticals, Inc. | 76.87M |
| AnaptysBio, Inc. | 33.86M |
| Kodiak Sciences, Inc. | 48.55M |